Clinical Trial 49410

North Las Vegas, NV 89030


A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of the Study Drug in Adult Subjects with Moderate-to-Severe Atopic Dermatitis Inadequately Controlled by Topical Treatments

  • Male or female aged ≥18 and ≤80 years of age.
  • Chronic AD that has been present for at least 3 years.
  • Documented recent history of inadequate response to treatment with topical medications such as topical corticosteroids, calcineurin inhibitors, or crisaborole for at least 4 weeks in the 6 months, or subjects for whom these topical treatments are otherwise medically inadvisable.
  • Involvement of at least 10% or more of BSA (body surface area).

Qualified Participants May Receive:

$200-$400 per in person visit. Total $4,000+.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.